CNTF Gene

CNTF Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CNTF Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CNTF</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ciliary Neurotrophic Factor</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>11q12.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1270</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000218792</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P26441</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>118200</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">R64G</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">A36V</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">Component</td>
<td>Role</td>
</tr>
<tr>
<td class="label">CNTFRα</td>
<td>Ligand-binding subunit</td>
</tr>
<tr>
<td class="label">GP130</td>
<td>Signal-transducing subunit</td>
</tr>
<tr>
<td class="label">LIFRβ</td>
<td>Signal-transducing subunit</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

CNTF Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CNTF Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CNTF</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ciliary Neurotrophic Factor</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>11q12.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1270</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000218792</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P26441</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>118200</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Type</td>
</tr>
<tr>
<td class="label">R64G</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">A36V</td>
<td>Missense</td>
</tr>
<tr>
<td class="label">Component</td>
<td>Role</td>
</tr>
<tr>
<td class="label">CNTFRα</td>
<td>Ligand-binding subunit</td>
</tr>
<tr>
<td class="label">GP130</td>
<td>Signal-transducing subunit</td>
</tr>
<tr>
<td class="label">LIFRβ</td>
<td>Signal-transducing subunit</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

The CNTF gene (Ciliary Neurotrophic Factor) encodes a neuroprotective cytokine that plays a critical role in the survival, development, and function of neurons throughout the central and peripheral nervous systems. CNTF belongs to the interleukin-6 family of cytokines and exerts potent neurotrophic effects that have been extensively studied in the context of neurodegenerative diseases, particularly Alzheimer's disease, Parkinson's disease, and motor neuron diseases. [@cntf2023]

Gene Overview

Protein Product

The CNTF protein is a 200-amino acid cytokine that is expressed primarily in the central nervous system. It is a globular protein belonging to the interleukin-6 family, characterized by a four-helix bundle structure. CNTF is primarily synthesized by [astrocytes](/cell-types/astrocytes) in the brain and by Schwann cells in the peripheral nervous system. [@structure2022]

Structure

• Molecular Weight: ~22.7 kDa (non-glycosylated)
• Structure: Four-helix bundle cytokine fold
• Signal Peptide: 26 amino acid N-terminal signal sequence
• Receptor Binding Sites: Multiple sites for receptor complex formation

Function

CNTF exerts its biological effects through binding to a tripartite receptor complex consisting of CNTFRα, GP130, and LIFRβ. This activates the JAK-STAT signaling pathway, particularly STAT3, leading to diverse neuroprotective effects:

Signaling Pathways

• JAK/STAT Pathway: Primary signaling cascade (JAK1/JAK2 → STAT3)
• MAPK Pathway: Secondary pathway for cell growth and differentiation
• PI3K/Akt Pathway: Pro-survival signaling

Disease Associations

Alzheimer's Disease

CNTF has complex relationships with AD pathophysiology:

• CNTF expression is altered in AD brains
• Exogenous CNTF can protect neurons against Aβ toxicity
• CNTF signaling may be impaired in AD
• The cytokine modulates neuroinflammation [@cntf2023a]

Parkinson's Disease

CNTF shows promise in PD research:

• Protects dopaminergic neurons from degeneration
• Promotes survival of substantia nigra neurons
• May enhance dopamine biosynthesis
• Animal models show behavioral improvement with CNTF delivery [@cntf2022]

Motor Neuron Disease

CNTF was one of the first neurotrophic factors tested in ALS:

• CNTF supports motor neuron survival
• Early clinical trials showed some promise but with significant side effects
• Gene therapy approaches are being explored to deliver CNTF safely
• Combined neurotrophic factor approaches may be more effective [@cntf2021a]

Other Conditions

• Peripheral Neuropathy: CNTF protects against chemotherapy-induced neuropathy
• Spinal Cord Injury: Promotes recovery in animal models
• Retinal Degeneration: Protects retinal ganglion cells

Mutations

Known Variants

Polymorphisms

• Various SNPs in the CNTF gene have been studied
• Some variants may influence neurodegenerative disease risk
• Gene-environment interactions are being investigated [@cntf2022a]

Therapeutic Relevance

Therapeutic Approaches

Challenges

• Side effects including weight loss and fever
• Limited CNS penetration
• Immune reactions to foreign protein
• Optimal delivery methods still being refined

Clinical Trials

• Early trials in ALS showed mixed results
• Ongoing studies in PD and AD
• Novel delivery systems under investigation [@gene2024]

Interactions

Receptor Complex

Downstream Effectors

• JAK1/JAK2: Tyrosine kinases
• STAT3: Transcription factor
• SOCS3: Negative regulator
• PIAS3: STAT3 inhibitor

Protein Interactions

• Interacts with various intracellular signaling molecules
• Cross-talk with other cytokine pathways
• Modulates inflammation through immune cell effects [@cntf2023b]

Research Directions

Current research areas include:

• Developing safer CNTF delivery methods
• Understanding CNTF's role in specific brain regions
• Combining CNTF with other neurotrophic factors
• Identifying biomarkers for CNTF-based therapies

References